Agus, Samuel
Sorbonne Université · Biophytis (France)
3 papers on CoChatORCID 0009-0008-0295-4744
Most cited papers
- Verified
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): A structured summary of a study protocol for a randomised controlled trial
Dioh, W., Chabane, M., Tourette, C., Azbekyan, A., Morelot-Panzini, C., Hajjar, L. A., Lins, M., Nair, G. B., Whitehouse, T., Mariani, J., et al. (2021) · Trials
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 33
- Verified
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
Lobo, S. M., Plantefève, G., Nair, G., Joaquim Cavalcante, A., Franzin de Moraes, N., Nunes, E., Barnum, O., Berdun Stadnik, C. M., Lima, M. P., Lins, M., et al. (2024) · eClinicalMedicine
COVID-19 Clinical Research StudiesRenin-Angiotensin System Studies
Cited by 27
- Verified
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial
Fielding, R. A., Dao, M. M., Cannon, K., Desvarieux, M., Miller, S. S., Gimness, M. P., Brandon, D. M., Villareal, D. T., Bruyere, O., Bautmans, I., et al. (2025) · Journal of Cachexia, Sarcopenia and Muscle
Nutrition and Health in AgingMuscle Physiology and Disorders
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free